Global Platinum based Cancer Drug Market Research Report 2018 Opportunities, Size, Cost Structure, Service Provider, Segmentation, Shares, Forecast to 2024

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Jul-2018   |    Format :PDF   |    Number of Pages : 172
This report studies the Platinum based Cancer Drug market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Platinum based Cancer Drug market by product type and applications/end industries.

In the last several years, global market of platinum based cancer drug developed smoothly, with an average growth rate of 4.29%. In 2017, global revenue of platinum based cancer drug is nearly 1285 M USD; the actual sales are about 27572 K units.


The major players in global Platinum based Cancer Drug market include
Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy's Laboratories
Mylan
Sun Pharma 
Novartis
Debiopharm
Accord Healthcare
SK Chemicals


Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth rate of Platinum based Cancer Drug in these regions, from 2013 to 2025 (forecast), covering
North America
Europe 
Asia-Pacific 
South America 
Middle East & Africa


On the basis of product, the Platinum based Cancer Drug market is primarily split into
Cisplatin
Oxaliplatin 
Carboplatin
Other

On the basis on the end users/applications, this report covers
Colorectal Cancer
Ovarian Cancer
Lung Cancer 
Other

1 Platinum based Cancer Drug Market Overview	1
1.1 Platinum based Cancer Drug Product Overview	1
1.2 Platinum based Cancer Drug Segment by Types (Product Category)	1
1.2.1 Global Platinum based Cancer Drug Sales by Types	1
1.2.2 Global Platinum based Cancer Drug Sales Market Share by Types in 2017	2
1.2.3 Cisplatin	3
1.2.4 Oxaliplatin	3
1.2.5 Carboplatin	4
1.3 Global Platinum based Cancer Drug Segment by Applications	4
1.3.1 Global Platinum based Cancer Drug Sales Comparison by Applications	4
1.3.2 Colorectal Cancer	5
1.3.3 Ovarian Cancer	6
1.3.4 Lung Cancer	6
1.4 Global Platinum based Cancer Drug Market by Regions (2013-2025)	7
1.4.1 Global Platinum based Cancer Drug Market Size Comparison by Regions (2013-2025)	7
1.4.2 North America Platinum based Cancer Drug Status and Prospect (2013-2025)	8
1.4.3 Europe Platinum based Cancer Drug Status and Prospect (2013-2025)	9
1.4.4 Asia-Pacific Platinum based Cancer Drug Status and Prospect (2013-2025)	10
1.4.5 South America Platinum based Cancer Drug Status and Prospect (2013-2025)	11
1.4.6 Middle East & Africa Platinum based Cancer Drug Status and Prospect (2013-2025)	12
1.5 Global Platinum based Cancer Drug Market Size (2013-2025)	13
1.5.1 Global Platinum based Cancer Drug Revenue Status and Outlook (2013-2025)	13
1.5.2 Global Platinum based Cancer Drug Sales Status and Outlook (2013-2025)	14
2 Global Platinum based Cancer Drug Market Competition by Manufacturers	15
2.1 Global Platinum based Cancer Drug Sales and Share by Manufacturers (2017-2018)	15
2.2 Global Platinum based Cancer Drug Revenue and Share by Manufacturers (2017-2018)	17
2.3 Global Platinum based Cancer Drug Average Price by Manufacturers (2017-2018)	20
2.4 Manufacturers Platinum based Cancer Drug Headquarters and Established	22
2.5 Platinum based Cancer Drug Market Competitive Situation and Trends	23
2.5.1 Platinum based Cancer Drug Market Concentration Rate	23
2.5.2 Platinum based Cancer Drug Market Share of Top 3 and Top 5 Manufacturers	24
2.5.3 Mergers & Acquisitions, Expansion	25
3 Global Platinum based Cancer Drug Sales by Regions (2013-2018)	30
3.1 Global Platinum based Cancer Drug Sales and Market Share by Regions (2013-2018)	30
3.2 Global Platinum based Cancer Drug Revenue and Market Share by Regions (2013-2018)	32
3.3 Global Platinum based Cancer Drug Sales, Revenue, Price (2013-2018)	35
3.4 North America Platinum based Cancer Drug Sales (2013-2018)	36
3.4.1 North America Platinum based Cancer Drug Sales and Growth Rate (2013-2018)	36
3.4.2 North America Platinum based Cancer Drug Sales, Revenue, Price (2013-2018)	36
3.5 Europe Platinum based Cancer Drug Sales (2013-2018)	37
3.5.1 Europe Platinum based Cancer Drug Sales and Growth Rate (2013-2018)	37
3.5.2 Europe Platinum based Cancer Drug Sales, Revenue, Price (2013-2018)	38
3.6 Asia-Pacific Platinum based Cancer Drug Sales (2013-2018)	39
3.6.1 Asia-Pacific Platinum based Cancer Drug Sales and Growth Rate (2013-2018)	39
3.6.2 Asia-Pacific Platinum based Cancer Drug Sales, Revenue, Price (2013-2018)	39
3.7 South America Platinum based Cancer Drug Sales (2013-2018)	40
3.7.1 South America Platinum based Cancer Drug Sales and Growth Rate (2013-2018)	40
3.7.2 South America Platinum based Cancer Drug Sales, Revenue, Price (2013-2018)	41
3.8 Middle East & Africa Platinum based Cancer Drug Sales (2013-2018)	42
3.8.1 Middle East & Africa Platinum based Cancer Drug Sales and Growth Rate (2013-2018)	42
3.8.2 Middle East & Africa Platinum based Cancer Drug Sales, Revenue, Price (2013-2018)	43
4 Global Platinum based Cancer Drug Sales, Revenue (Value), Price Trend by Types	44
4.1 Global Platinum based Cancer Drug Sales and Market Share by Types (2013-2018)	44
4.2 Global Platinum based Cancer Drug Revenue and Market Share by Types (2013-2018)	46
4.3 Global Platinum based Cancer Drug Price by Types (2013-2018)	48
4.4 Global Platinum based Cancer Drug Sales Growth Rate by Types (2013-2018)	48
5 Global Platinum based Cancer Drug Market Analysis by Applications	49
5.1 Global Platinum based Cancer Drug Sales and Market Share by Applications (2013-2018)	49
5.2 Global Platinum based Cancer Drug Sales Growth Rate by Applications (2013-2018)	51
6 Analysis of Platinum based Cancer Drug Industry Key Manufacturers	52
6.1 Sanofi	52
6.1.1 Company Profile	52
6.1.2 Product Information	53
6.1.3 Sales, Price, Cost, Gross, and Revenue	54
6.2 Hengrui Medicine	54
6.2.1 Company Profile	54
6.2.2 Product Information	55
6.2.3 Sales, Price, Cost, Gross, and Revenue	56
6.3 ASK Pharma	56
6.3.1 Company Profile	56
6.3.2 Product Information	57
6.3.3 Sales, Price, Cost, Gross, and Revenue	57
6.4 Yi Bai Pharmaceutical	58
6.4.1 Company Profile	58
6.4.2 Product Information	59
6.4.3 Sales, Price, Cost, Gross, and Revenue	59
6.5 Qilu Pharmaceutical	60
6.5.1 Company Profile	60
6.5.2 Product Information	61
6.5.3 Sales, Price, Cost, Gross, and Revenue	61
6.6 Teva	61
6.6.1 Company Profile	61
6.6.2 Product Information	63
6.6.3 Sales, Price, Cost, Gross, and Revenue	63
6.7 Pfizer	64
6.7.1 Company Profile	64
6.7.2 Product Information	65
6.7.3 Sales, Price, Cost, Gross, and Revenue	65
6.8 Dr Reddy’s Laboratories	66
6.8.1 Company Profile	66
6.8.2 Product Information	67
6.8.3 Sales, Price, Cost, Gross, and Revenue	67
6.9 Mylan	68
6.9.1 Company Profile	68
6.9.2 Product Information	69
6.9.3 Sales, Price, Cost, Gross, and Revenue	69
6.10 Sun Pharma	70
6.10.1 Company Profile	70
6.10.2 Product Information	71
6.10.3 Sales, Price, Cost, Gross, and Revenue	71
6.11 Novartis	72
6.11.1 Company Profile	72
6.11.2 Product Information	73
6.11.3 Sales, Price, Cost, Gross, and Revenue	73
6.12 Debiopharm	74
6.12.1 Company Profile	74
6.12.2 Product Information	75
6.12.3 Sales, Price, Cost, Gross, and Revenue	75
6.13 Accord Healthcare	76
6.13.1 Company Profile	76
6.13.2 Product Information	77
6.13.3 Sales, Price, Cost, Gross, and Revenue	77
6.14 SK Chemicals	78
6.14.1 Company Profile	78
6.14.2 Product Information	79
6.14.3 Sales, Price, Cost, Gross, and Revenue	79
7 Platinum based Cancer Drug Manufacturing Cost Analysis	80
7.1 Platinum based Cancer Drug R&D Cost Analysis	80
7.1.1Clinical Phase Costs	81
7.1.2 Capitalized Costs	82
7.2 Proportion of Manufacturing Cost Structure	83
7.2.1 Raw Materials	83
7.2.2 Labor Cost	84
7.2.2.1 USA Labor Cost Analysis	84
7.2.2.2 Europe Labor Costs Analysis	85
7.2.2.3 Asia Labor Costs Analysis	87
7.2.3 Other Costs Analysis	88
7.2.3.1 USA Cost of Electricity Analysis	88
7.2.3.2 USA Water Cost Analysis	88
7.2.3.3 Europe Cost of Electricity Analysis	89
7.2.3.4 Europe Water Cost Analysis	90
7.2.3.5 China Cost of Electricity Analysis	91
7.2.3.6 China Water Cost Analysis	92
7.3 Manufacturing Process Analysis of Platinum based Cancer Drug	93
8 Industrial Chain, Sourcing Strategy and Downstream Buyers	94
8.1 Platinum based Cancer Drug Industrial Chain Analysis	94
8.2 Upstream Raw Materials Sourcing	95
8.3 Downstream Buyers	95
9 Marketing Strategy Analysis, Distributors/Traders	98
9.1 Marketing Channel	98
9.1.1 Direct Marketing	100
9.1.2 Indirect Marketing	100
9.1.3 Marketing Channel Development Trend	101
9.2 Market Positioning	102
9.2.1 Pricing Strategy	102
9.2.2 Brand Strategy	103
9.3 Distributors/Traders List	104
10 Market Effect Factors Analysis	107
10.1 Technology Progress/Risk	107
10.1.1 New Active Substance Launches 2011-2015 by Indication	107
10.1.2 Rapid Uptake of New Immune-oncology Drugs Reflects Their Remarkable Clinical Profile and Expansion of Indications	108
10.1.3 Technology Progress in Related Industry	109
10.2 Cancer Patients Analysis	112
10.2.1 Key Facts	112
10.2.2 Cancer Incidence and Mortality Analysis	114
10.3 Economic/Political Environmental Change	115
11 Global Platinum based Cancer Drug Market Forecast (2019-2025)	124
11.1 Global Platinum based Cancer Drug Sales, Revenue Forecast (2019-2025)	124
11.1.1 Global Platinum based Cancer Drug Sales and Growth Rate Forecast (2019-2025)	124
11.1.2 Global Platinum based Cancer Drug Revenue and Growth Rate Forecast (2019-2025)	125
11.1.3 Global Platinum based Cancer Drug Price and Trend Forecast (2019-2025)	126
11.2 Global Platinum based Cancer Drug Sales Forecast by Regions (2019-2025)	126
11.2.1 North America Platinum based Cancer Drug Sales and Revenue Forecast (2019-2025)	128
11.2.2 Europe Platinum based Cancer Drug Sales and Revenue Forecast (2019-2025)	130
11.2.3 Asia-Pacific Platinum based Cancer Drug Sales and Revenue Forecast (2019-2025)	132
11.2.4 South America Platinum based Cancer Drug Sales and Revenue Forecast (2019-2025)	134
11.2.5 Middle East & Africa Platinum based Cancer Drug Sales and Revenue Forecast (2019-2025)	136
11.3 Global Platinum based Cancer Drug Revenue Forecast by Regions (2019-2025)	137
11.3.1 North America Platinum based Cancer Drug Revenue Forecast (2019-2025)	139
11.3.2 Europe Platinum based Cancer Drug Revenue Forecast (2019-2025)	140
11.3.3 Asia-Pacific Platinum based Cancer Drug Revenue Forecast (2019-2025)	141
11.3.4 South America Platinum based Cancer Drug Revenue Forecast (2019-2025)	142
11.3.5 Middle East & Africa Platinum based Cancer Drug Revenue Forecast (2019-2025)	143
11.4 Global Platinum based Cancer Drug Sales, Revenue and Price Forecast by Types (2019-2025)	143
11.4.1 Global Platinum based Cancer Drug Sales Forecast by Types (2019-2025)	143
11.4.2 Global Platinum based Cancer Drug Revenue Forecast by Types (2019-2025)	145
11.4.3 Global Platinum based Cancer Drug Price Forecast by Types (2019-2025)	147
11.5 Global Platinum based Cancer Drug Sales Forecast by Application (2019-2025)	148
12 Research Findings and Conclusion	150
13 Methodology and Data Source	151
13.1 Methodology/Research Approach	151
13.1.1 Research Programs/Design	151
13.1.2 Market Size Estimation	152
1.3 Market Breakdown and Data Triangulation	153
13.2 Data Source	154
13.2.1 Secondary Sources	154
13.2.2 Primary Sources	155
13.3 Author List	156
13.4 Disclaimer	157



List of Tables and Figures

Figure Product Picture of Platinum based Cancer Drug	1
Table Global Platinum based Cancer Drug Sales (K Unit) Comparison by Types (2013-2025)	1
Figure Global Platinum based Cancer Drug Sales Market Share by Types in 2017	2
Figure Product Picture of Cisplatin	3
Figure Product Picture of Oxaliplatin	3
Figure Product Picture of Carboplatin	4
Table Global Platinum based Cancer Drug Sales (K Unit) Comparison by Applications (2013-2025)	4
Figure Global Platinum based Cancer Drug Sales Market Share by Applications in 2017	5
Figure Colorectal Cancer Examples	5
Figure Ovarian Cancer Examples	6
Figure Lung Cancer Examples	6
Table Global Platinum based Cancer Drug Market Size (M USD) Comparison by Regions (2013-2025)	7
Figure North America Platinum based Cancer Drug Revenue (M USD) and Growth Rate (2013-2025)	8
Figure Europe Platinum based Cancer Drug Revenue (M USD) and Growth Rate (2013-2025)	9
Figure Asia-Pacific Platinum based Cancer Drug Revenue (M USD) and Growth Rate (2013-2025)	10
Figure South America Platinum based Cancer Drug Revenue (M USD) and Growth Rate (2013-2025)	11
Figure Middle East & Africa Platinum based Cancer Drug Revenue (M USD) and Growth Rate (2013-2025)	12
Figure Global Platinum based Cancer Drug Revenue (M USD) Status and Outlook (2013-2025)	13
Figure Global Platinum based Cancer Drug Sales (K Unit) Status and Outlook (2013-2025)	14
Table Global Platinum based Cancer Drug Sales (K Unit) of Key Manufacturers (2017-2018)	15
Table Global Platinum based Cancer Drug Sales Market Share by Manufacturers (2017-2018)	15
Figure 2017 Platinum based Cancer Drug Sales Market Share by Manufacturers	16
Figure 2018 Platinum based Cancer Drug Sales Market Share by Manufacturers	17
Table Global Platinum based Cancer Drug Revenue (M USD) by Manufacturers (2017-2018)	17
Table Global Platinum based Cancer Drug Revenue Share by Manufacturers (2017-2018)	18
Figure 2017 Global Platinum based Cancer Drug Revenue Share by Manufacturers	19
Figure 2018 Global Platinum based Cancer Drug Revenue Share by Manufacturers	20
Table Global Market Platinum based Cancer Drug Average Price (USD/Unit) of Key Manufacturers (2017-2018)	20
Figure Global Market Platinum based Cancer Drug Average Price (USD/Unit) of Key Manufacturers in 2017	21
Table Manufacturers Platinum based Cancer Drug Headquarters and Established	22
Figure 2017 Platinum based Cancer Drug Revenue Market Share by Manufacturers	23
Figure 2017 Platinum based Cancer Drug Revenue Market Share of Top 3 Manufacturers	24
Figure 2017 Platinum based Cancer Drug Revenue Market Share of Top 5 Manufacturers	25
Table Global Platinum based Cancer Drug Sales (K Unit) by Regions (2013-2018)	30
Table Global Platinum based Cancer Drug Sales Market Share by Regions (2013-2018)	30
Figure Global Platinum based Cancer Drug Sales Market Share by Regions (2013-2018)	31
Figure 2017 Global Platinum based Cancer Drug Sales Market Share by Regions	31
Table Global Platinum based Cancer Drug Revenue (M USD) by Regions (2013-2018)	32
Table Global Platinum based Cancer Drug Revenue Market Share by Regions (2013-2018)	32
Figure Global Platinum based Cancer Drug Revenue Market Share by Regions (2013-2018)	33
Figure 2017 Global Platinum based Cancer Drug Revenue Market Share by Regions	34
Figure Global Platinum based Cancer Drug Sales (K Unit) and Growth Rate (2013-2018)	35
Table Global Platinum based Cancer Drug Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018)	35
Figure North America Platinum based Cancer Drug Sales (K Unit) and Growth Rate (2013-2018)	36
Table North America Platinum based Cancer Drug Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018)	36
Figure Europe Platinum based Cancer Drug Sales (K Unit) and Growth Rate (2013-2018)	37
Table Europe Platinum based Cancer Drug Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018)	38
Figure Asia-Pacific Platinum based Cancer Drug Sales (K Unit) and Growth Rate (2013-2018)	39
Table Asia-Pacific Platinum based Cancer Drug Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018)	39
Figure South America Platinum based Cancer Drug Sales (K Unit) and Growth Rate (2013-2018)	40
Table South America Platinum based Cancer Drug Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018)	41
Figure Middle East & Africa Platinum based Cancer Drug Sales (K Unit) and Growth Rate (2013-2018)	42
Table Middle East & Africa Platinum based Cancer Drug Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018)	43
Table Global Platinum based Cancer Drug Sales (K Unit) by Types (2013-2018)	44
Table Global Platinum based Cancer Drug Sales Market Share by Types (2013-2018)	44
Figure Sales Market Share of Platinum based Cancer Drug by Types (2013-2018)	45
Figure 2017 Sales Market Share of Platinum based Cancer Drug by Types	45
Table Global Platinum based Cancer Drug Revenue (M USD) by Types (2013-2018)	46
Table Global Platinum based Cancer Drug Revenue Share by Types (2013-2018)	46
Figure Revenue Share of Platinum based Cancer Drug by Types (2013-2018)	47
Figure 2017 Revenue Market Share of Platinum based Cancer Drug by Types	47
Table Global Platinum based Cancer Drug Price (USD/Unit) by Types (2013-2018)	48
Figure Global Platinum based Cancer Drug Sales Growth Rate by Types (2013-2018)	48
Table Global Platinum based Cancer Drug Sales (K Unit) by Applications (2013-2018)	49
Table Global Platinum based Cancer Drug Sales Market Share by Applications (2013-2018)	49
Figure Global Platinum based Cancer Drug Sales Market Share by Applications (2013-2018)	50
Figure Global Platinum based Cancer Drug Sales Market Share by Applications in 2017	50
Figure Global Platinum based Cancer Drug Sales Growth Rate by Applications (2013-2018)	51
Table Sanofi Company Profile	52
Figure Platinum based Cancer Drug Product Picture of Sanofi	53
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi 2017-2018	54
Table Hengrui Medicine Company Profile	54
Figure Platinum based Cancer Drug Product Picture of Hengrui Medicine	55
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Hengrui Medicine 2017-2018	56
Table ASK Pharma Company Profile	56
Figure Platinum based Cancer Drug Product Picture of ASK Pharma	57
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of ASK Pharma 2017-2018	57
Table Yi Bai Pharmaceutical Company Profile	58
Figure Platinum based Cancer Drug Product Picture of Yi Bai Pharmaceutical	59
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Yi Bai Pharmaceutical 2017-2018	59
Table Qilu Pharmaceutical Company Profile	60
Figure Platinum based Cancer Drug Product Picture of Qilu Pharmaceutical	61
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Qilu Pharmaceutical 2017-2018	61
Table Teva Company Profile	61
Figure Platinum based Cancer Drug Product Picture of Teva	63
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Teva 2017-2018	63
Table Pfizer Company Profile	64
Figure Platinum based Cancer Drug Product Picture of Pfizer	65
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2017-2018	65
Table Dr Reddy’s Laboratories Company Profile	66
Figure Platinum based Cancer Drug Product Picture of Dr Reddy’s Laboratories	67
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Dr Reddy’s Laboratories 2017-2018	67
Table Mylan Company Profile	68
Figure Platinum based Cancer Drug Product Picture of Mylan	69
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Mylan 2017-2018	69
Table Sun Pharma Company Profile	70
Figure Platinum based Cancer Drug Product Picture of Sun Pharma	71
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sun Pharma 2017-2018	71
Table Novartis Company Profile	72
Figure Platinum based Cancer Drug Product Picture of Novartis	73
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Novartis 2017-2018	73
Table Debiopharm Company Profile	74
Figure Platinum based Cancer Drug Product Picture of Debiopharm	75
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Debiopharm 2017-2018	75
Table Accord Healthcare Company Profile	76
Figure Platinum based Cancer Drug Product Picture of Accord Healthcare	77
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Accord Healthcare 2017-2018	77
Table SK Chemicals Company Profile	78
Figure Platinum based Cancer Drug Product Picture of SK Chemicals	79
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of SK Chemicals 2017-2018	79
Figure typical phases from research to the market for a drug candidate	81
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound	82
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound	83
Figure Manufacturing Cost Structure of Platinum based Cancer Drug	83
Figure USA Labor Cost Analysis 2013-2018	84
Figure Cost of Employing a Factory Worker	85
Figure 2016 Estimated Labour Costs for the Whole Economy in Europe	86
Figure Monthly Minimum Wages in Asia 2016	87
Figure China Labor Costs 2013-2016	87
Table Average Price of Electricity to Ultimate Customers 2007-2016	88
Figure Electricity Prices for Household Consumers in 2016	89
Figure Summary of the Driving Assumptions	91
Figure Industrial Electric Rates 2016 (PER KWH)	91
Figure Manufacturing Process Analysis of Platinum based Cancer Drug	93
Figure Platinum based Cancer Drug Industrial Chain Analysis	94
Table Major Buyers of Platinum based Cancer Drug	95
Figure Marketing Channel for Biopharmaceuticals	98
Figure Conceptual Model of the Flow of Products, Services and Funds for Non-specialty Drugs Coveredunder Private Insurance and Purchased in a Retail Setting	99
Figure Marketing Channel for Biopharmaceuticals	100
Figure Flow of US Prescription Sales Contribution by Channel	101
Figure Setting Pricing Policy	102
Table Distributors/Traders List	104
Figure New Active Substance Launches 2011-2015 by Indication	107
Figure Immuno-Oncology PD-1 Inhibitor Uptake in the U.S.	108
Figure Growth of the Late Phase Oncology Pipeline, 2005-2015	109
Figure Key In-Market and Investigational Agents for NSCLC	110
Figure Key In-Market and Investigational Agents for Melanoma	110
Figure the Global Late Phase Oncology Pipeline in 2015	111
Figure Companies with Active Late Phase Oncology Pipelines	112
Figure Cancer Incidence by Country in 2014	114
Figure Cancer Mortality by Country in 2014	114
Figure USA numbers of new cancer cases for 2015	115
Figure Global GDP Growth Rate for 2016	116
Figure Real GDP Growth 2016-2020 annual Average	117
Figure USA GDP 2008-2016 (Billion USD)	118
Figure USA GDP Growth Rate Change 2015-2018	118
Figure EU GDP 2008-2016 (Billion USD)	119
Figure EU GDP Growth Rate Change 2015-2018	119
Figure Germany GDP 2008-2016 (Billion USD)	120
Figure Germany GDP Growth Rate 2015-2018	120
Figure UK GDP 2008-2016 (Billion USD)	120
Figure UK GDP Growth Rate 2015-2018	121
Figure Italy GDP 2008-2016 (Billion USD)	121
Figure Italy GDP Growth Rate 2015-2018	121
Figure France GDP 2008-2016 (Billion USD)	122
Figure France GDP Growth Rate 2015-2018	122
Figure Japan GDP 2008-2016 (Billion USD)	122
Figure Japan GDP Growth Rate 2015-2018	123
Figure China GDP 2008-2016 (Billion USD)	123
Figure China GDP Growth Rate 2015-2018	123
Figure Global Platinum based Cancer Drug Sales (K Unit) and Growth Rate Forecast (2019-2025)	124
Figure Global Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025)	125
Figure Global Platinum based Cancer Drug Price (USD/Unit) Trend Forecast (2019-2025)	126
Table Global Platinum based Cancer Drug Sales (K Unit) Forecast by Regions (2019-2025)	126
Figure Global Platinum based Cancer Drug Sales Market Share Forecast by Regions (2019-2025)	127
Figure Global Platinum based Cancer Drug Sales Market Share Forecast by Regions in 2025	127
Figure North America Platinum based Cancer Drug Sales (K Unit) and Growth Rate Forecast (2019-2025)	128
Figure North America Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025)	129
Figure Europe Platinum based Cancer Drug Sales (K Unit) and Growth Rate Forecast (2019-2025)	130
Figure Europe Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025)	131
Figure Asia-Pacific Platinum based Cancer Drug Sales (K Unit) and Growth Rate Forecast (2019-2025)	132
Figure Asia-Pacific Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025)	133
Figure South America Platinum based Cancer Drug Sales (K Unit) and Growth Rate Forecast (2019-2025)	134
Figure South America Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025)	135
Figure Middle East & Africa Platinum based Cancer Drug Sales (K Unit) and Growth Rate Forecast (2019-2025)	136
Figure Middle East & Africa Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025)	137
Table Global Platinum based Cancer Drug Revenue (M USD) Forecast by Regions (2019-2025)	137
Figure Global Platinum based Cancer Drug Revenue Market Share Forecast by Regions (2019-2025)	138
Figure Global Platinum based Cancer Drug Revenue Market Share Forecast by Regions in 2025	138
Figure North America Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025)	139
Figure Europe Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025)	140
Figure Asia-Pacific Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025)	141
Figure South America Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025)	142
Figure Middle East & Africa Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025)	143
Table Global Platinum based Cancer Drug Sales (K Unit) Forecast by Types (2019-2025)	143
Table Global Platinum based Cancer Drug Sales Market Share Forecast by Types (2019-2025)	144
Figure Global Platinum based Cancer Drug Sales Market Share Forecast by Types (2019-2025)	144
Figure Global Platinum based Cancer Drug Sales Market Share Forecast by Types in 2025	145
Table Global Platinum based Cancer Drug Revenue (M USD) Forecast by Types (2019-2025)	145
Table Global Platinum based Cancer Drug Revenue Market Share Forecast by Types (2019-2025)	145
Figure Global Platinum based Cancer Drug Revenue Market Share Forecast by Types (2019-2025)	146
Figure Global Platinum based Cancer Drug Revenue Market Share Forecast by Types in 2025	147
Table Global Platinum based Cancer Drug Price (USD/Unit) Forecast by Types (2019-2025)	147
Table Global Platinum based Cancer Drug Sales (K Unit) Forecast by Application (2019-2025)	148
Table Global Platinum based Cancer Drug Sales Market Share Forecast by Application (2019-2025)	148
Figure Global Platinum based Cancer Drug Sales Market Share Forecast by Application (2019-2025)	149
Figure Global Platinum based Cancer Drug Sales Market Share Forecast by Application in 2025	149

Latest News

25-Feb-2019 | Medical Devices

Launch Of Symjepi Epinephrine Syringe To Boost The Syringe Market Growth In US

A rising burden of chronic diseases has been observed all across the world, which, in turn, has elevated the usage of syringes. Overall, the global syringe market is anticipated to observe vigorous ...

25-Feb-2019 | Electrical & Electronic Device

Launch Of Xiaomi Set-Top Box To Power The Global 4K Set-Top Box Market

While smart TVs are turning out to be much more widespread these days, a number of consumers still choose to opt for normal TVs and then employ smart streaming set top box with them. Popular choice ...

13-Feb-2019 | Software

Bioinspired Artificial Bug Eye Creation Is A Baton For Global Autonomous Car Market

After looking at the different eye lens structures of the animals and humans, the researchers have decided on creating a sharp image using its design. The compound eyes of the bugs are currently be ...

13-Feb-2019 | Consumer Goods & Retailing

Cafe X’s $12 Million “Seed-1” Round To Boost The Global Coffee Market

Cafe X, a company engaged in building robot baristas, is about to raise a $12 Million “Seed-1” round. Recently, Crunchbase News broke the story when it came across regulatory f ...

05-Feb-2019 | Chemicals & Materials

Clinically Produced Cells Change The Horizon Of Global Bone Cement And Glue Market

The group of researchers from the New York Stem Cell Foundation Research Institute published an article in Stem Cell Research and Therapy where the details regarding the clinical ...